Journal profile · HEALTH CARE SCIENCES & SERVICES
Global & Regional Health Technology Assessment
ISSN 2284-2403 · eISSN 2283-5733 · AboutScience Srl · Italy
Global & Regional Health Technology Assessment: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC charged, amount not published; median 120 days to acceptance (70 articles, last 24 months); 36 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Global & Regional Health Technology Assessment is published by AboutScience Srl and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy and Economic and Financial Impacts of Cancer, together about 54.1% of its articles. Its main subfields are Economics and Econometrics. (generated from OpenAlex topic counts and CAS ranking data)
Health technology assessment (HTA) is a discipline in which global policies and guidelines are applied at regional level. Global and Regional Health Technology Assessment (GRHTA) is an international, indexed, peer-reviewed, open access, online only journal, which aims to promote health technology assessment and economic evaluation globally and/or regionally, supporting the decision-making process among alternative therapeutical approaches and technologies with different clinical and economic outcomes.
From the journal's Aims & Scope
Research area (LetPub): HEALTH CARE SCIENCES & SERVICES
Editor-in-chief Claudio JommiPublisher website
Editorial board by country: none in mainland China; most named Italy 5, United Kingdom 1, Ireland 1 (7 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance29.1%
- Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance17.3%
- Economic and Financial Impacts of CancerEconomics, Econometrics and Finance7.8%
- Biosimilars and Bioanalytical MethodsImmunology and Microbiology5.7%
- Pharmaceutical studies and practicesMedicine3.2%
- Chronic Lymphocytic Leukemia ResearchMedicine2.5%
- Healthcare cost, quality, practicesHealth Professions2.5%
- Diabetes Treatment and ManagementMedicine2.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Health Care Sciences & Services | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Health Care Sciences & Services | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.9LetPub ·
- SJR 2026-06
- 0.24LetPub ·
- SNIP 2026-06
- 0.37LetPub ·
- h-index
- 11OpenAlex ·
- i10-index
- 14OpenAlex ·
- 2-year mean citedness
- 0.94OpenAlex ·
- Self-citation rate
- 14.3%LetPub ·
- Share of gold OA articles
- 98.77%LetPub ·
Volume
- Articles per year
- 33LetPub ·
Articles by year OpenAlex count · 468 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 32 | 32 | 6 |
| 2025 | 36 | 36 | 34 |
| 2024 | 40 | 40 | 62 |
| 2023 | 15 | 15 | 32 |
| 2022 | 30 | 30 | 40 |
| 2021 | 24 | 24 | 82 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
120 daysMedian, submission to acceptance · P25–P75 87 days – 164 days
- Acceptance to online
- median 28 days (70 articles)
- Submission to online
- median 148 days
- Sample
- 70 articles with submission and acceptance dates (76 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 8 weeksLetPub ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 1,500 | No | CC BY-NC | |
| OpenAlex | EUR 1,500 | — | — | |
| LetPub | EUR 1,500 | No | — | |
| Publisher website | Yes, amount not published | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Abstract
- ≤ 250 words
- Templates
- Word
Policy excerpts from the journal's websiteAI use
- AI use Use of artificial intelligence to draft a mini-HTA report on a new medical device belonging to class IIb–III
Andrea Messori, Sabrina Beltramini, Paola Crosasso, Claudia Fruttero, Melania Rivano, Marco Chiumente, Maria C Silvani 55-57 PDF ePub DOI: https://doi.org/10.33393/grhta.2026.3691
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- AboutScience Srl
- Country or region
- Italy
- Language
- English, Spanish, Italian
- ISSN
- 2284-2403
- Electronic ISSN
- 2283-5733
- Latest issue on the website
- Volume 13, Issue 1 (2026)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Global & Regional Health Technology Assessment
What CAS zone is Global & Regional Health Technology Assessment in?
In the 2025 upgraded edition of the CAS Journal Ranking, Global & Regional Health Technology Assessment is in Zone 4 of Medicine, and in Zone 4 of the minor category Health Care Sciences & Services. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Global & Regional Health Technology Assessment?
Based on the dates recorded on 70 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 120 days (interquartile range 87–164 days); authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Global & Regional Health Technology Assessment?
According to the journal's author guidelines: Abstract: ≤ 250 words; Templates: Word. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Global & Regional Health Technology Assessment based?
Of the 7 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Italy (5), United Kingdom (1) and Ireland (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Global & Regional Health Technology Assessment?
According to LetPub and DOAJ records, Global & Regional Health Technology Assessment is indexed in ESCI, Scopus and DOAJ.
Is Global & Regional Health Technology Assessment open access, and what is the APC?
Global & Regional Health Technology Assessment is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .